Early recruitment of underrepresented minorities to biomedical and health research training is essential to ensure that society's diversity is reflected in those professions. The objective of this proposal is to strengthen its partners'capabilities to contribute to significant increases in the participation of underrepresented minorities in nationally competitive cancer clinical and basic research. The University of Puerto Rico (UPR) and the University of Texas M. D. Anderson Cancer Center (MDACC) will continue to develop a comprehensive pipeline program from undergraduates to postgraduates that will increase the number of Hispanic students knowledgeable and committed to careers in cancer research and cancer medicine. The overall goal of this project is to encourage Hispanic science and medical students to pursue careers in cancer research and medicine and populate the faculty ranks at the UPR so as to strengthen cancer research at the University of Puerto Rico. The University of Puerto Rico (UPR) is conducting the training program with MDACC in several areas - biomedical and clinical research, didactics, enrichment experiences, M.D./PhD. training, postgraduate clinical training, training in cancer prevention and health disparities, and career development. The desired outcome will be achieved through a coordinated series of didactic and research experiences and enrichment activities that include on-campus cancer research at University of Puerto Rico Comprehensive Cancer Center (UPRCCC) during the academic year and summer research and year-round rotations to MDACC. The program draws upon the strengths of both institutions and brings benefits to both.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
3U54CA096297-11S1
Application #
8756111
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y (O1))
Project Start
2002-08-16
Project End
2018-08-31
Budget Start
2013-09-25
Budget End
2014-08-31
Support Year
11
Fiscal Year
2013
Total Cost
$43,881
Indirect Cost
$14,627
Name
University of Puerto Rico Med Sciences
Department
Type
DUNS #
948108063
City
San Juan
State
PR
Country
United States
Zip Code
00936
Juan-Rivera, Maylein C; Martínez-Ferrer, Magaly (2018) Integrin Inhibitors in Prostate Cancer. Cancers (Basel) 10:
Cruz-Correa, Marcia; Hylind, Linda M; Marrero, Jessica Hernandez et al. (2018) Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis. Gastroenterology 155:668-673
Gonzalez-Mercado, Velda J; Fridley, Brooke L; Saligan, Leorey N (2018) Sestrin family of genes and their role in cancer-related fatigue. Support Care Cancer 26:2071-2074
Villar-Prados, Alejandro; Wu, Sherry Y; Court, Karem A et al. (2018) Predicting novel therapies and targets: Regulation of Notch3 by the bromodomain protein BRD4. Mol Cancer Ther :
Allen, Julie K; Armaiz-Pena, Guillermo N; Nagaraja, Archana S et al. (2018) Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction. Cancer Res 78:3233-3242
Marqués-Lespier, Juan M; Soto-Salgado, Marievelisse; González-Pons, María et al. (2018) Prevalence of Synchronous Oligopolyposis in Incident Colorectal Cancer: A Population-Based Study. P R Health Sci J 37:39-45
Maldonado, María Del Mar; Dharmawardhane, Suranganie (2018) Targeting Rac and Cdc42 GTPases in Cancer. Cancer Res 78:3101-3111
González-Pons, María; Soto-Salgado, Marievelisse; Sevilla, Javier et al. (2018) Seroprevalence of Helicobacter pylori in Hispanics living in Puerto Rico: A population-based study. Helicobacter 23:
Monroig-Bosque, Paloma Del C; Shah, Maitri Y; Fu, Xiao et al. (2018) OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers. Sci Rep 8:13106
Das, Soma; Parga, Kenia; Chakraborty, Indranil et al. (2018) Magnetic resonance imaging contrast enhancement in vitro and in vivo by octanuclear iron-oxo cluster-based agents. J Inorg Biochem 186:176-186

Showing the most recent 10 out of 157 publications